Legato Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,190
| Closed | -$936K | – | 588 |
|
|
2025
Q1 | $936K | Buy |
+5,190
| New | +$936K | 0.13% | 273 |
|
|
2024
Q4 | – | Sell |
-1,791
| Closed | -$326K | – | 597 |
|
|
2024
Q3 | $326K | Sell |
1,791
-431
| -19% | -$78.5K | 0.04% | 501 |
|
|
2024
Q2 | $408K | Buy |
+2,222
| New | +$408K | 0.06% | 466 |
|
|
2024
Q1 | – | Sell |
-5,099
| Closed | -$633K | – | 594 |
|
|
2023
Q4 | $633K | Sell |
5,099
-5,841
| -53% | -$725K | 0.08% | 362 |
|
|
2023
Q3 | $1.27M | Sell |
10,940
-1,795
| -14% | -$208K | 0.18% | 185 |
|
|
2023
Q2 | $1.5M | Buy |
12,735
+1,795
| +16% | +$211K | 0.2% | 159 |
|
|
2023
Q1 | $876K | Hold |
10,940
| – | – | 0.16% | 223 |
|
|
2022
Q4 | $867K | Buy |
+10,940
| New | +$867K | 0.17% | 206 |
|
|
2021
Q3 | – | Sell |
-5,882
| Closed | -$400K | – | 266 |
|
|
2021
Q2 | $400K | Buy |
+5,882
| New | +$400K | 0.06% | 275 |
|